Top 10 Companies in the (S)-N-BOC-2-Bromophenylalanine (CAS 261165-02-0) Market (2026): Market Leaders Powering Global Pharmaceutical Innovation

MARKET INSIGHTS

Global (S)-N-BOC-2-Bromophenylalanine (CAS 261165-02-0) market size was valued at USD 28.4 million in 2025. The market is projected to grow from USD 30.1 million in 2026 to USD 52.6 million by 2034, exhibiting a CAGR of 6.4% during the forecast period.

(S)-N-BOC-2-Bromophenylalanine (CAS 261165-02-0) is a protected, enantiomerically pure unnatural amino acid derivative featuring a bromine substituent at the ortho position of the phenylalanine aromatic ring, with the amine group safeguarded by a tert-butoxycarbonyl (BOC) protecting group. This compound serves as a critical building block in peptide synthesis, medicinal chemistry, and pharmaceutical research, enabling the precise construction of complex peptide sequences and peptidomimetics with defined stereochemistry.

The market is witnessing steady growth driven by rising demand for specialty amino acid building blocks in drug discovery and the accelerating pace of peptide-based therapeutics development. Furthermore, the growing adoption of solid-phase peptide synthesis (SPPS) across pharmaceutical and biotechnology research laboratories globally continues to expand the addressable market. Key suppliers operating in this space include Sigma-Aldrich (Merck KGaA), Bachem AG, and Combi-Blocks, Inc., among other fine chemical manufacturers maintaining robust portfolios of protected amino acid derivatives.

(S)-N-BOC-2-Bromophenylalanine (CAS 261165-02-0) Market – View in Detailed Research Report

🔟 1. Sigma‑Aldrich (Merck KGaA)

Headquarters: Darmstadt, Germany / St. Louis, USA
Key Offering: Comprehensive catalog of chiral amino acid derivatives including high‑purity (S)-N-BOC-2‑Bromophenylalanine.

Sigma‑Aldrich is a global leader in specialty chemicals, providing a wide range of protected amino acids for pharmaceutical, biotechnology, and academic research. Their (S)-N‑BOC‑2‑Bromophenylalanine is available in pharmaceutical grade with ≥99% ee, supported by rigorous analytical validation and full documentation for GMP‑compliant supply.

Sustainability & Growth Initiatives: Investment in green chemistry processes to reduce solvent usage and waste generation in amino acid synthesis.

• Advanced asymmetric hydrogenation platforms for scalable production.
• Collaborations with academic institutions for novel SAR studies.
• Digital supply chain tracking for real‑time inventory management.

9️⃣ 2. Bachem AG

Headquarters: Basel, Switzerland
Key Offering: Custom synthesis of protected amino acids and peptidomimetics for drug discovery.

Bachem specializes in high‑quality chiral intermediates and offers bespoke manufacturing for pharmaceutical clients. Their (S)-N‑BOC‑2‑Bromophenylalanine is produced under cGMP conditions with detailed certificates of analysis and stability data.

Sustainability & Growth Initiatives: Commitment to circular chemistry by reusing by‑products and reducing energy consumption.

• Integration of continuous flow reactors for scalable synthesis.
• Partnerships with contract development organizations (CDMOs) for early‑stage pipeline support.
• Implementation of ISO 14001 environmental management systems.

8️⃣ 3. Combi‑Blocks, Inc.

Headquarters: New York, USA
Key Offering: Ready‑to‑use protected amino acids and custom synthesis services.

Combi‑Blocks provides high‑purity (S)-N‑BOC‑2‑Bromophenylalanine for both research and pharmaceutical production, with flexible batch sizes and rapid turnaround times.

Sustainability & Growth Initiatives: Adoption of renewable energy sources for manufacturing facilities.

• Rapid scale‑up capabilities for early‑stage drug candidates.
• Collaborations with CROs for SAR library development.
• ISO 9001 quality management system.

7️⃣ 4. AK Scientific, Inc.

Headquarters: San Diego, USA
Key Offering: Fine chemicals and custom synthesis of specialty amino acids.

AK Scientific delivers (S)-N‑BOC‑2‑Bromophenylalanine with stringent purity controls and offers cGMP‑qualified production for clinical candidates.

Sustainability & Growth Initiatives: Implementation of water‑recycling systems in production lines.

• Custom chiral synthesis routes for unique SAR requirements.
• Partnerships with academic research labs for novel peptide designs.
• Digital analytics platform for real‑time process monitoring.

6️⃣ 5. Ark Pharm, Inc.

Headquarters: Irvine, USA
Key Offering: Broad portfolio of halogenated amino acid derivatives.

Ark Pharm supplies high‑purity (S)-N‑BOC‑2‑Bromophenylalanine to pharmaceutical companies, supporting both research and cGMP manufacturing.

Sustainability & Growth Initiatives: Reduction of hazardous waste through process optimization.

• Integration of automated purification systems.
• Collaborations with CDMOs for scalable synthesis.
• ISO 14001 environmental certification.

5️⃣ 6. Fluorochem Ltd.

Headquarters: London, United Kingdom
Key Offering: Catalog supply of high‑purity specialty amino acids.

Fluorochem offers (S)-N‑BOC‑2‑Bromophenylalanine for research‑grade applications with comprehensive analytical data and batch records.

Sustainability & Growth Initiatives: Use of biodegradable solvents in synthesis.

• Support for academic and industrial research projects.
• Rapid sample procurement for early‑stage discovery.
• Compliance with EU REACH regulations.

4️⃣ 7. TCI Chemicals

Headquarters: Tokyo, Japan
Key Offering: Fine chemical catalog for medicinal chemistry.

TCI provides (S)-N‑BOC‑2‑Bromophenylalanine with detailed purity specifications suitable for preclinical studies.

Sustainability & Growth Initiatives: Energy‑efficient manufacturing processes.

• Collaboration with Japanese pharmaceutical firms for pipeline development.
• Implementation of lean manufacturing principles.
• ISO 9001 quality management.

3️⃣ 8. Jinan Chenghui‑Shuangda Chemical Co., Ltd.

Headquarters: Jinan, China
Key Offering: Cost‑effective production of protected amino acids.

Jinan Chenghui‑Shuangda offers (S)-N‑BOC‑2‑Bromophenylalanine at competitive pricing, supporting both research and small‑scale pharmaceutical synthesis.

Sustainability & Growth Initiatives: Adoption of waste‑minimization protocols.

• Rapid scale‑up for medium‑volume production.
• Partnerships with local biotech hubs.
• Compliance with China GMP standards.

2️⃣ 9. Hangzhou Keying Chem Co., Ltd.

Headquarters: Hangzhou, China
Key Offering: Bulk production of protected amino acids.

Hangzhou Keying delivers high‑purity (S)-N‑BOC‑2‑Bromophenylalanine for research and pharmaceutical applications, with flexible order sizes.

Sustainability & Growth Initiatives: Implementation of green chemistry guidelines.

• Continuous flow synthesis for scalability.
• Collaboration with Chinese pharmaceutical companies.
• ISO 14001 environmental management.

1️⃣ 10. Jiangsu Fine Chemicals Co., Ltd.

Headquarters: Suzhou, China
Key Offering: Bulk supply of specialty amino acids.

Jiangsu Fine Chemicals provides (S)-N‑BOC‑2‑Bromophenylalanine at large scale, supporting global research and pharmaceutical markets.

Sustainability & Growth Initiatives: Focus on energy‑efficient production and waste reduction.

• Large‑scale batch production with rapid turnaround.
• Partnerships with international CROs.
• Compliance with international quality standards.

Download FREE Sample Report: (S)-N-BOC-2-Bromophenylalanine (CAS 261165-02-0) Market – View in Detailed Research Report

Get Full Report Here: (S)-N-BOC-2-Bromophenylalanine (CAS 261165-02-0) Market – View in Detailed Research Report

🌍 Outlook: The Future of (S)-N-BOC-2-Bromophenylalanine Market

The (S)-N‑BOC‑2‑Bromophenylalanine market is poised for sustained growth as peptide‑based therapeutics expand across oncology, metabolic disorders, and rare diseases. The increasing adoption of solid‑phase peptide synthesis (SPPS) and the rise of targeted protein degradation (PROTACs) and covalent inhibitors will further drive demand for high‑purity, enantiomerically defined building blocks. Manufacturers that combine advanced chiral synthesis, robust quality systems, and integrated contract manufacturing services are best positioned to capture this expanding market.

📈 Future Trends Shaping the Market

• Accelerated development of PROTACs and molecular glues requiring specialized halogenated amino acids.
• Growth of green chemistry initiatives to reduce solvent and energy consumption in amino acid synthesis.
• Expansion of contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs) offering end‑to‑end synthesis and regulatory support.
• Increasing demand for high‑purity, cGMP‑qualified intermediates to support late‑stage clinical development.
• Digitalization of supply chain management for real‑time tracking and compliance.